SCHEMBL18178078

SCHEMBL18178078

CCc1cc(C)ccc1OCc1ccccc1OC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PTGER1 P34995 4/20 0.48
PTGER4 P35408 3/20 0.48
PTGER3 P43115 3/20 0.48
PTGER2 P43116 3/20 0.48
PTGDR2 Q9Y5Y4 1/20 0.42
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
MAPT P10636 3/20 0.40
HTT P42858 2/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18138655 0.88 FFAR4 (0.49) L3MBTL1PTGER1PTGER4PTGER3PTGER2
SCHEMBL18178489 0.88 L3MBTL1 (0.48) KDM4EL3MBTL1PTGER1PTGER4PTGER3
SCHEMBL18178168 0.88 KDM4E (0.45) KDM4EL3MBTL1PTGER1PTGER4PTGER3
SCHEMBL18182151 0.87 FFAR4 (0.43) KDM4EL3MBTL1PTGER1PTGDR2HSD17B10
SCHEMBL18178111 0.86 MRGPRX4 (0.50) KDM4EL3MBTL1PTGER1PTGER4PTGER3
SCHEMBL18178053 0.86 MRGPRX4 (0.50) KDM4EL3MBTL1PTGDR2HSD17B10HPGD
SCHEMBL18178061 0.86 MAPT (0.50) KDM4EL3MBTL1HPGDMAPTHTT
SCHEMBL18178386 0.86 PTGDR2 (0.43) KDM4EPTGER1PTGDR2HSD17B10HPGD
SCHEMBL18178109 0.85 L3MBTL1 (0.41) KDM4EL3MBTL1PTGER1PTGER4PTGER3
SCHEMBL18182760 0.85 PTGDR2 (0.42) KDM4EPTGER1PTGDR2HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 KDM4E 2107/4885L3MBTL1 401/4885PTGER1 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.